374 related articles for article (PubMed ID: 25034865)
1. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
3. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q
Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934
[TBL] [Abstract][Full Text] [Related]
5. Accelerated Caco-2 cell permeability model for drug discovery.
Sevin E; Dehouck L; Fabulas-da Costa A; Cecchelli R; Dehouck MP; Lundquist S; Culot M
J Pharmacol Toxicol Methods; 2013; 68(3):334-9. PubMed ID: 23916595
[TBL] [Abstract][Full Text] [Related]
6. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
7. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
Fisher SJ; Swaan PW; Eddington ND
J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
[TBL] [Abstract][Full Text] [Related]
8. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
9. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
10. HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption model.
Augustijns P; Mols R
J Pharm Biomed Anal; 2004 Mar; 34(5):971-8. PubMed ID: 15019031
[TBL] [Abstract][Full Text] [Related]
11. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
12. New and better protocols for a short-term Caco-2 cell culture system.
Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
[TBL] [Abstract][Full Text] [Related]
14. Development of a quantitative LC-MS/MS analytical method coupled with turbulent flow chromatography for digoxin for the in vitro P-gp inhibition assay.
Smalley J; Marino AM; Xin B; Olah T; Balimane PV
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):260-7. PubMed ID: 17524973
[TBL] [Abstract][Full Text] [Related]
15. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model.
Zhu ML; Liang XL; Zhao LJ; Liao ZG; Zhao GW; Cao YC; Zhang J; Luo Y
J Ethnopharmacol; 2013 Nov; 150(2):553-9. PubMed ID: 24076259
[TBL] [Abstract][Full Text] [Related]
19. Development of an automated 7-day 96-well Caco-2 cell culture model.
Galkin A; Pakkanen J; Vuorela P
Pharmazie; 2008 Jun; 63(6):464-9. PubMed ID: 18604991
[TBL] [Abstract][Full Text] [Related]
20. Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and in vivo.
Yoshida N; Takagi A; Kitazawa H; Kawakami J; Adachi I
J Pharm Sci; 2006 Mar; 95(3):552-60. PubMed ID: 16419049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]